Previously, CDDO-Me and CDDO-Im were shown to increase the expression of JUN (1 μM; H157 cells (2–8 h)) [138] and FOS (0.2 μM (6 h)) [66] in human lung cancer cells and HUVEC, respectively. Here, FOS is linked to lung carcinoma.